Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $331,272 - $389,373
-32,100 Reduced 61.49%
20,100 $233,000
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $500,490 - $598,596
-49,800 Reduced 48.82%
52,200 $554,000
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $543,214 - $652,146
-48,200 Reduced 32.09%
102,000 $1.22 Million
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $1.26 Million - $1.56 Million
-144,200 Reduced 48.98%
150,200 $1.63 Million
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $586,908 - $694,620
61,200 Added 26.24%
294,400 $2.9 Million
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $304,876 - $347,802
33,800 Added 16.95%
233,200 $2.33 Million
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $782,919 - $1.04 Million
85,100 Added 74.45%
199,400 $1.92 Million
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $730,736 - $968,728
83,800 Added 274.75%
114,300 $1.27 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $216,240 - $283,815
25,500 Added 510.0%
30,500 $260,000
Q2 2022

Aug 08, 2022

SELL
$9.95 - $12.27 $844,754 - $1.04 Million
-84,900 Reduced 94.44%
5,000 $52,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $464,013 - $728,420
47,300 Added 111.03%
89,900 $978,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $5.99 Million - $7.28 Million
-495,800 Reduced 92.09%
42,600 $577,000
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $4.48 Million - $5.12 Million
338,100 Added 168.8%
538,400 $7.3 Million
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $1.62 Million - $2.02 Million
125,100 Added 166.36%
200,300 $2.86 Million
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $1.19 Million - $1.62 Million
-87,480 Reduced 53.77%
75,200 $1.05 Million
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $2.33 Million - $3.05 Million
162,680 New
162,680 $3.05 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.